Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.

The American journal of gastroenterology - 1 Aug 2000

Yatsuoka T, Sunamura M, Furukawa T, Fukushige S, Yokoyama T, Inoue H, Shibuya K, Takeda K, Matsuno S, Horii A

Abstract excerpt

OBJECTIVE: Pancreatic cancer is one of the diseases with the poorest prognosis, but the associated genetic alterations are not yet well understood. The genetic alterations reported to date in pancreatic cancer include frequent mutations of the KRAS, TP53, p16, and SMAD4 genes. Mutation of the TP53 gene was reported to be associated with a poor prognosis. In this study, we analyzed the association of loss of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Mapping

Share to Loss of Heterozygosity

Share to Multivariate Analysis

Share to Pancreatic Neoplasms

Share to Prognosis

Share to Survival Analysis

Source

Identifiers

PMID: 10950061
DOI: 10.1111/j.1572-0241.2000.02171.x

Genes

SMAD4
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.PMID 10950061Read ↗

Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.Semantic proximity Read ↗

Chromosome 17p allelic loss in colorectal carcinoma. Clinical significance.Semantic proximity Read ↗

Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis.Semantic proximity Read ↗

Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.Semantic proximity Read ↗

Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations.Semantic proximity Read ↗

Molecular genetic changes in human epithelial ovarian malignancies.Semantic proximity Read ↗

Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome.Semantic proximity Read ↗

Allelotyping for loss of heterozygosity on chromosome 18 in gastric cancer.Semantic proximity Read ↗

Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.Semantic proximity Read ↗

Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.Semantic proximity Read ↗

The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma.Semantic proximity Read ↗

Allelotype of pancreatic acinar cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.